Developer docs
API playgroundTry for free, no card

Search company profiles

WinVision

Full company profile

uuid003e8bu

Namestring
WinVision
Legal namestring
WinVision (A Division of Micropolis Lifesciences Pvt. Ltd.)
Company typeenum
Private
Founded yearstring
-
Descriptiontext

WinVision is the ophthalmic pharmaceutical division of Micropolis Lifesciences Pvt. Ltd., a privately held Indian pharma group headquartered in Panchkula, Haryana. The company manufactures a focused range of eye-care formulations spanning antibiotic and anti-inflammatory eye drops (BACTWIST series), lubricant and dry-eye drops (LUBRIKEY, TEARPOLIS, PEGWIN), anti-allergy drops (OLOTWIST), steroid and NSAID drops (LOTEKEY, FLURWIN, NEPATWIST), antifungal drops (NATAVISION), intraocular-pressure management drops (TIMOTWIST), adjunct gels (GANCITWIST, TEARPOLIS EYE GEL), ophthalmic ointments, softgel antioxidant capsules, syrups, and an incoming eye-health gummy line. Manufacturing is conducted in a single WHO-GMP certified facility in Panchkula, with H.A.C.C.P. food-safety compliance also claimed; the R&D function focuses on formulation innovation in ophthalmology rather than novel-molecule development.

The company's revenue model is centered on a PCD (Propaganda Cum Distribution) pharma franchise system: WinVision grants monopoly territorial distribution rights to franchise partners, supplies them with marketing collateral (visual aids, sample packs, doctor lists, promotional merchandise), and sells finished ophthalmic products through that network. Customers include PCD franchisees, doctors and ophthalmologists, hospitals and clinics, pharmaceutical wholesalers, retailers, medical representatives, and area/regional managers. Pricing is quote-based and not publicly disclosed, with multi-year franchise contracts underlying the business relationship.

Operating geographies are domestic-only, with franchise recruitment actively marketed across states including Gujarat, Telangana, Tamil Nadu, West Bengal, Punjab, Jammu & Kashmir, Maharashtra, and Madhya Pradesh. Sister concerns Gynopolis (gynecology) and Win Fertility operate under the same Micropolis Lifesciences parent, giving the group a multi-therapeutic footprint. The company has been in operation for over 20 years with no public funding rounds, no acquisitions, and no disclosed revenue figures.

Short descriptiontext

WinVision is the ophthalmic pharmaceutical division of Micropolis Lifesciences Pvt. Ltd., manufacturing eye drops, capsules, ointments, syrups, and gummies at a WHO-GMP facility in Panchkula and selling through a PAN India PCD franchise network.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersPanchkula, India
HQ citystring
Panchkula
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ophthalmic pharmaceuticals, eye drops manufacturing, PCD pharma franchise, eye care products, ophthalmic formulations
Industry2 codes
PRIMARYHLAIACAK
Ophthalmology Specialty Pharmaceuticals
SECONDARYHLAIAAAL
Ophthalmology Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Ophthalmic Pharmaceuticals
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Pharmaceutical Product Sales
TypeOne Time License
Description

WinVision generates revenue through manufacturing and distributing ophthalmic pharmaceutical products including eye drops, capsules, tablets, syrups, ointments, and gummies. Revenue flows through PCD franchise partners who purchase products for redistribution in their assigned territories.

winvisionindia.com
2PCD Franchise Rights
TypeLicensing Royalties
Description

The company offers monopoly rights to franchise partners for exclusive distribution in assigned geographic areas. Franchise partners invest in distribution rights and purchase products for resale.

winvisionindia.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Pharmaceutical products sold through PCD franchise model
ModelOtherBilling cadenceMulti-year contract
Notes

Product pricing is provided upon inquiry. The company offers franchise opportunities with monopoly rights across different territories.

winvisionindia.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

WinVision manufactures and distributes a comprehensive portfolio of ophthalmic pharmaceutical products including eye drops, capsules, tablets, syrups, ointments, and gummies. The company operates on a PCD (Propaganda Cum Distribution) pharma franchise model across India, offering monopoly territorial rights to franchise partners along with marketing collateral, training, and dedicated logistics for product delivery.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Products manufactured and dispatched on time through dedicated logistics team
+1 more record
Product overview1 text field

WinVision is a pharmaceutical company specializing in ophthalmic (eye care) products, operating as a division of Micropolis Lifesciences Pvt. Ltd. The company offers a comprehensive portfolio of eye care formulations organized across five main product categories: Eye Drops (including antibiotic, anti-inflammatory, anti-allergy, lubricant, and antifungal formulations), Eye Ointments, Capsules (soft gelatin capsules for oral eye health supplementation), Gummies (edible eye health supplements), and Syrups. The eye drops portfolio includes combination products like BACTWIST series (BACTWIST, BACTWIST-BF, BACTWIST-DX, BACTWIST-KT, BACTWIST-LT, BACTWIST-PD), LUBRIKEY series (LUBRIKEY, LUBRIKEY PLUS, LUBRIKEY ULTRA), OLOTWIST series (OLOTWIST, OLOTWIST KT, OLOTWIST-LS), TEARPOLIS series (TEARPOLIS, TEARPOLIS PLUS, TEARPOLIS EYE GEL), and specialty products like CATAKEY, NEPATWIST, LOTEKEY, TIMOTWIST, NATAVISION, and others. The capsule line includes WINVISION S.G.C and WINVISION FORTE S.G.C softgel capsules. The company operates on a PCD (Propaganda Cum Distribution) pharma franchise business model offering monopoly rights to distribution partners across India.

Product and service31 records
1BACTWIST Eye Drops
CategoryEye Drops
2BACTWIST-BF Eye Drops
CategoryEye Drops
3BACTWIST-DX Eye Drops
CategoryEye Drops
4BACTWIST-KT Eye Drops
CategoryEye Drops
5BACTWIST LT Eye Drops
CategoryEye Drops
6LUBRIKEY Eye Drops
CategoryEye Drops
7LUBRIKEY PLUS Eye Drops
CategoryEye Drops
8LUBRIKEY ULTRA Eye Drops
CategoryEye Drops
9OLOTWIST Eye Drops
CategoryEye Drops
10OLOTWIST KT Eye Drops
CategoryEye Drops
11OLOTWIST-LS Eye Drops
CategoryEye Drops
12TEARPOLIS Eye Drops
CategoryEye Drops
13TEARPOLIS PLUS Eye Drops
CategoryEye Drops
14TEARPOLIS EYE GEL
CategoryEye Drops
15CATAKEY Eye Drops
CategoryEye Drops
16NEPATWIST Eye Drops
CategoryEye Drops
17LOTEKEY Eye Drops
CategoryEye Drops
18TIMOTWIST Eye Drops
CategoryEye Drops
19TOBATWIST Eye Drops
CategoryEye Drops
20GATPOLIS Eye Drops
CategoryEye Drops
21NAPHAPOLIS Eye Drops
CategoryEye Drops
22FLURWIN Eye Drops
CategoryEye Drops
23BACSTATIK Eye/Ear Drops
CategoryEye Drops
24NATAVISION Eye Drops
CategoryEye Drops
25PEGWIN Eye Drops
CategoryEye Drops
26RIPDRY Eye Drops
CategoryEye Drops
27GANCITWIST EYE GEL
CategoryEye Drops
28AZIMICRO EYE OINTMENT
CategoryOintments
29WINVISION S.G.C Capsules
CategoryCapsules
30WINVISION FORTE S.G.C Capsules
CategoryCapsules
31WINVISION GUMMIES
CategoryGummies
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierMinorTypeOthers
Description

Gynopolis is listed as a sister concern of WinVision. It appears to be a related company under the same corporate umbrella, possibly operating in a different therapeutic area (gynecology based on the name).

Strategic tierMinorTypeOthers
Description

Win Fertility is listed as a sister concern of WinVision, operating under the Micropolis Lifesciences Pvt. Ltd. umbrella. It focuses on fertility-related pharmaceutical products.

Strategic tierCoreTypeOthers
Description

WinVision is a division of Micropolis Lifesciences Pvt. Ltd. The parent company owns and operates multiple pharmaceutical divisions including WinVision (ophthalmics) and Win Fertility (fertility products).

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Indian pharmaceutical company with a dedicated ophthalmic division offering eye drops and related formulations. Comparable as a broad incumbent with overlapping ophthalmic products and Indian prescriber relationships.

TypeDirect peer
Description

Indian pharmaceutical company with a significant ophthalmic franchise business offering PCD opportunities and a wide ophthalmic product range. Closely comparable to WinVision in its PCD-driven ophthalmic specialty positioning in India.

3Centaur Pharmaceuticals
TypeDirect peer
Description

India-focused pharmaceutical company with a strong ophthalmology franchise (e.g., Moxicip, Lupituss) and active PCD/distribution model. Closely comparable as a mid-sized Indian ophthalmic specialist using similar franchise distribution.

TypeBroad incumbent
Description

Large Indian pharmaceutical company with ophthalmic and other therapeutic segments. Competes with WinVision in the ophthalmic space with deeper resources and broader portfolio.

TypeBroad incumbent
Description

Top Indian pharma company with ophthalmic and other therapeutic segments. Operates as a broad incumbent with deeper resources, competing on similar ophthalmic molecules and prescribers as WinVision.

TypeBroad incumbent
Description

Global leader in eye care across surgical, vision care, and ophthalmic pharmaceuticals. Broad incumbent providing advanced ophthalmic drugs, contact lenses, and surgical devices that compete with portions of WinVision's product range, particularly in India through its local presence.

TypeDirect peer
Description

India-focused ophthalmic specialty pharma with a strong PCD franchise network across India. Directly comparable to WinVision in therapeutic focus, target customers, and franchise-driven distribution model.

8Sun Pharmaceutical Industries
TypeBroad incumbent
Description

India's largest pharma company with a substantial ophthalmic portfolio (including SUN pharma's branded generics and combination products). It is a broad incumbent that competes with WinVision across the ophthalmic molecule space but at significantly larger scale.

TypeBroad incumbent
Description

Major Indian pharmaceutical company with ophthalmic and respiratory divisions, offering eye drops and related products through extensive field force distribution. Comparable as a broad incumbent targeting similar Indian prescribers with overlapping molecules.

TypeBroad incumbent
Description

Global ophthalmic-focused company offering pharmaceuticals, contact lenses, and surgical products. Comparable as a broad incumbent with significant ophthalmic pharma overlap that competes for prescribers and shelf space in India.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

WinVision

Ophthalmic Pharmaceuticalswinvisionindia.com

WinVision is the ophthalmic pharmaceutical division of Micropolis Lifesciences Pvt. Ltd., manufacturing eye drops, capsules, ointments, syrups, and gummies at a WHO-GMP facility in Panchkula and selling through a PAN India PCD franchise network.

What WinVision does

WinVision is the ophthalmic pharmaceutical division of Micropolis Lifesciences Pvt. Ltd., a privately held Indian pharma group headquartered in Panchkula, Haryana. The company manufactures a focused range of eye-care formulations spanning antibiotic and anti-inflammatory eye drops (BACTWIST series), lubricant and dry-eye drops (LUBRIKEY, TEARPOLIS, PEGWIN), anti-allergy drops (OLOTWIST), steroid and NSAID drops (LOTEKEY, FLURWIN, NEPATWIST), antifungal drops (NATAVISION), intraocular-pressure management drops (TIMOTWIST), adjunct gels (GANCITWIST, TEARPOLIS EYE GEL), ophthalmic ointments, softgel antioxidant capsules, syrups, and an incoming eye-health gummy line. Manufacturing is conducted in a single WHO-GMP certified facility in Panchkula, with H.A.C.C.P. food-safety compliance also claimed; the R&D function focuses on formulation innovation in ophthalmology rather than novel-molecule development.

The company's revenue model is centered on a PCD (Propaganda Cum Distribution) pharma franchise system: WinVision grants monopoly territorial distribution rights to franchise partners, supplies them with marketing collateral (visual aids, sample packs, doctor lists, promotional merchandise), and sells finished ophthalmic products through that network. Customers include PCD franchisees, doctors and ophthalmologists, hospitals and clinics, pharmaceutical wholesalers, retailers, medical representatives, and area/regional managers. Pricing is quote-based and not publicly disclosed, with multi-year franchise contracts underlying the business relationship.

Operating geographies are domestic-only, with franchise recruitment actively marketed across states including Gujarat, Telangana, Tamil Nadu, West Bengal, Punjab, Jammu & Kashmir, Maharashtra, and Madhya Pradesh. Sister concerns Gynopolis (gynecology) and Win Fertility operate under the same Micropolis Lifesciences parent, giving the group a multi-therapeutic footprint. The company has been in operation for over 20 years with no public funding rounds, no acquisitions, and no disclosed revenue figures.

WinVision firmographics

Firmographics
Name
WinVision
Legal name
WinVision (A Division of Micropolis Lifesciences Pvt. Ltd.)
Website
https://winvisionindia.com
Company type
Private
Operating status
Operating
Short description
WinVision is the ophthalmic pharmaceutical division of Micropolis Lifesciences Pvt. Ltd., manufacturing eye drops, capsules, ointments, syrups, and gummies at a WHO-GMP facility in Panchkula and selling through a PAN India PCD franchise network.
Ownership category
akta.pro rank

WinVision industry classification

Industry
Product category
Ophthalmic Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIACAK
Ophthalmology Specialty Pharmaceuticals
SECONDARYHLAIAAAL
Ophthalmology Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Ophthalmic pharmaceuticals
  • Eye drops manufacturing
  • PCD pharma franchise
  • Eye care products
  • Ophthalmic formulations

Where WinVision is headquartered

Location

Headquarters

HQ city
Panchkula
HQ country
India
HQ region
Asia

Offices1 record

Markets served

WinVision business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Pharmaceutical Product Sales: WinVision generates revenue through manufacturing and distributing ophthalmic pharmaceutical products including eye drops, capsules, tablets, syrups, ointments, and gummies. Revenue flows through PCD franchise partners who purchase products for redistribution in their assigned territories.
  2. PCD Franchise Rights: The company offers monopoly rights to franchise partners for exclusive distribution in assigned geographic areas. Franchise partners invest in distribution rights and purchase products for resale.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractPharmaceutical products sold through PCD franchise model

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

WinVision product offering

Product offering

Core offering

WinVision manufactures and distributes a comprehensive portfolio of ophthalmic pharmaceutical products including eye drops, capsules, tablets, syrups, ointments, and gummies. The company operates on a PCD (Propaganda Cum Distribution) pharma franchise model across India, offering monopoly territorial rights to franchise partners along with marketing collateral, training, and dedicated logistics for product delivery.

Product overview

WinVision is a pharmaceutical company specializing in ophthalmic (eye care) products, operating as a division of Micropolis Lifesciences Pvt. Ltd. The company offers a comprehensive portfolio of eye care formulations organized across five main product categories: Eye Drops (including antibiotic, anti-inflammatory, anti-allergy, lubricant, and antifungal formulations), Eye Ointments, Capsules (soft gelatin capsules for oral eye health supplementation), Gummies (edible eye health supplements), and Syrups. The eye drops portfolio includes combination products like BACTWIST series (BACTWIST, BACTWIST-BF, BACTWIST-DX, BACTWIST-KT, BACTWIST-LT, BACTWIST-PD), LUBRIKEY series (LUBRIKEY, LUBRIKEY PLUS, LUBRIKEY ULTRA), OLOTWIST series (OLOTWIST, OLOTWIST KT, OLOTWIST-LS), TEARPOLIS series (TEARPOLIS, TEARPOLIS PLUS, TEARPOLIS EYE GEL), and specialty products like CATAKEY, NEPATWIST, LOTEKEY, TIMOTWIST, NATAVISION, and others. The capsule line includes WINVISION S.G.C and WINVISION FORTE S.G.C softgel capsules. The company operates on a PCD (Propaganda Cum Distribution) pharma franchise business model offering monopoly rights to distribution partners across India.

Differentiator

Problem solved

Functional benefit

Products and services

  • BACTWIST Eye Drops
  • BACTWIST-BF Eye Drops
  • BACTWIST-DX Eye Drops
  • BACTWIST-KT Eye Drops
  • BACTWIST LT Eye Drops
  • LUBRIKEY Eye Drops
  • LUBRIKEY PLUS Eye Drops
  • LUBRIKEY ULTRA Eye Drops
  • OLOTWIST Eye Drops
  • OLOTWIST KT Eye Drops
  • OLOTWIST-LS Eye Drops
  • TEARPOLIS Eye Drops
  • TEARPOLIS PLUS Eye Drops
  • TEARPOLIS EYE GEL
  • CATAKEY Eye Drops
  • NEPATWIST Eye Drops
  • LOTEKEY Eye Drops
  • TIMOTWIST Eye Drops
  • TOBATWIST Eye Drops
  • GATPOLIS Eye Drops
  • NAPHAPOLIS Eye Drops
  • FLURWIN Eye Drops
  • BACSTATIK Eye/Ear Drops
  • NATAVISION Eye Drops
  • PEGWIN Eye Drops
  • RIPDRY Eye Drops
  • GANCITWIST EYE GEL
  • AZIMICRO EYE OINTMENT
  • WINVISION S.G.C Capsules
  • WINVISION FORTE S.G.C Capsules
  • WINVISION GUMMIES

Quantifiable outcome

  • Products manufactured and dispatched on time through dedicated logistics team
  • +1 more outcomes

Companies that use WinVision

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles3 records

WinVision technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

WinVision partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered minor and core.

  • GynopolisminorOthersGynopolis is listed as a sister concern of WinVision. It appears to be a related company under the same corporate umbrella, possibly operating in a different therapeutic area (gynecology based on the name).
  • Win FertilityminorOthersWin Fertility is listed as a sister concern of WinVision, operating under the Micropolis Lifesciences Pvt. Ltd. umbrella. It focuses on fertility-related pharmaceutical products.
  • Micropolis Lifesciences Pvt. Ltd.coreOthersWinVision is a division of Micropolis Lifesciences Pvt. Ltd. The parent company owns and operates multiple pharmaceutical divisions including WinVision (ophthalmics) and Win Fertility (fertility products).

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

WinVision competitors and assessment

Company assessment

Broad incumbents

  • Alembic Pharmaceuticals: Indian pharmaceutical company with a dedicated ophthalmic division offering eye drops and related formulations. Comparable as a broad incumbent with overlapping ophthalmic products and Indian prescriber relationships.
  • Intas Pharmaceuticals: Large Indian pharmaceutical company with ophthalmic and other therapeutic segments. Competes with WinVision in the ophthalmic space with deeper resources and broader portfolio.
  • Lupin Limited: Top Indian pharma company with ophthalmic and other therapeutic segments. Operates as a broad incumbent with deeper resources, competing on similar ophthalmic molecules and prescribers as WinVision.
  • Alcon: Global leader in eye care across surgical, vision care, and ophthalmic pharmaceuticals. Broad incumbent providing advanced ophthalmic drugs, contact lenses, and surgical devices that compete with portions of WinVision's product range, particularly in India through its local presence.
  • Sun Pharmaceutical Industries: India's largest pharma company with a substantial ophthalmic portfolio (including SUN pharma's branded generics and combination products). It is a broad incumbent that competes with WinVision across the ophthalmic molecule space but at significantly larger scale.
  • Cipla Limited: Major Indian pharmaceutical company with ophthalmic and respiratory divisions, offering eye drops and related products through extensive field force distribution. Comparable as a broad incumbent targeting similar Indian prescribers with overlapping molecules.
  • Bausch + Lomb: Global ophthalmic-focused company offering pharmaceuticals, contact lenses, and surgical products. Comparable as a broad incumbent with significant ophthalmic pharma overlap that competes for prescribers and shelf space in India.

Direct peers

  • Ajanta Pharma: Indian pharmaceutical company with a significant ophthalmic franchise business offering PCD opportunities and a wide ophthalmic product range. Closely comparable to WinVision in its PCD-driven ophthalmic specialty positioning in India.
  • Centaur Pharmaceuticals: India-focused pharmaceutical company with a strong ophthalmology franchise (e.g., Moxicip, Lupituss) and active PCD/distribution model. Closely comparable as a mid-sized Indian ophthalmic specialist using similar franchise distribution.
  • Entod Pharmaceuticals: India-focused ophthalmic specialty pharma with a strong PCD franchise network across India. Directly comparable to WinVision in therapeutic focus, target customers, and franchise-driven distribution model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

WinVision compliance and trust

Trust signal

Compliance2 records

WinVision financial estimates

Financial estimate

Revenue estimate

Valuation estimate

WinVision leadership team

Management profile

Number of profiles

WinVision subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

WinVision funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

WinVision M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about WinVision

What does WinVision do?

WinVision manufactures and distributes a comprehensive portfolio of ophthalmic pharmaceutical products including eye drops, capsules, tablets, syrups, ointments, and gummies. The company operates on a PCD (Propaganda Cum Distribution) pharma franchise model across India, offering monopoly territorial rights to franchise partners along with marketing collateral, training, and dedicated logistics for product delivery.

Is WinVision a public or private company?

WinVision is a private company. It is classified as corporate owned and is currently operating.

When was WinVision founded?

WinVision was founded in -1.

Where is WinVision based?

WinVision is headquartered in Panchkula, India, in the Asia region.

How does WinVision make money?

Two revenue lines are on record. Pharmaceutical Product Sales are the primary driver. The others are PCD Franchise Rights.

Who are WinVision's main competitors?

Broad incumbents on record are Alembic Pharmaceuticals, Intas Pharmaceuticals, Lupin Limited, Alcon, Sun Pharmaceutical Industries, Cipla Limited and Bausch + Lomb. Direct peers are Ajanta Pharma, Centaur Pharmaceuticals and Entod Pharmaceuticals.

Does WinVision have an API?

No public API is recorded for WinVision.

What industry is WinVision in?

WinVision's product category is Ophthalmic Pharmaceuticals. Its primary akta.pro industry code is HLAIACAK, Ophthalmology Specialty Pharmaceuticals, with a secondary code of HLAIAAAL, Ophthalmology Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales